Quantum Genomics Société Anonyme (QNNTF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.13 Million EUR | 88.49% |
| 2022 | -30.08 Million EUR | -31.59% |
| 2021 | -22.86 Million USD | -11.0% |
| 2020 | -20.59 Million USD | -70.51% |
| 2019 | -12.07 Million USD | 22.3% |
| 2018 | -15.54 Million USD | -25.78% |
| 2017 | -12.35 Million USD | -88.5% |
| 2016 | -6.55 Million USD | -35.67% |
| 2015 | -4.83 Million USD | -46.3% |
| 2014 | -3.3 Million USD | -25.7% |
| 2013 | -2.62 Million USD | -0.24% |
| 2012 | -2.62 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.2 Million USD | 0.0% |
| 2023 FY | -3.48 Million USD | 88.43% |
| 2023 Q3 | -605.8 Thousand USD | 72.24% |
| 2023 Q4 | -632.61 Thousand USD | -4.43% |
| 2023 Q2 | -2.18 Million USD | -102.06% |
| 2023 Q1 | -1.07 Million USD | 90.14% |
| 2022 FY | -30.08 Million EUR | -31.59% |
| 2022 Q4 | -10.95 Million USD | -9.27% |
| 2022 Q3 | -10.02 Million USD | 25.59% |
| 2022 Q2 | -13.47 Million USD | 0.0% |
| 2021 Q2 | -8.97 Million USD | 0.0% |
| 2021 FY | -22.86 Million USD | -11.0% |
| 2020 FY | -20.59 Million USD | -70.51% |
| 2019 Q4 | -6.1 Million USD | 0.0% |
| 2019 FY | -12.07 Million USD | 22.3% |
| 2019 Q2 | -6.06 Million USD | 0.0% |
| 2018 Q4 | -7.75 Million USD | 0.0% |
| 2018 FY | -15.54 Million USD | -25.78% |
| 2018 Q2 | -7.95 Million USD | 0.0% |
| 2017 Q4 | -6.95 Million USD | 0.0% |
| 2017 FY | -12.35 Million USD | -88.5% |
| 2017 Q2 | -5.13 Million USD | 0.0% |
| 2016 Q2 | -3.41 Million USD | 0.0% |
| 2016 Q4 | -3.31 Million USD | 0.0% |
| 2016 FY | -6.55 Million USD | -35.67% |
| 2015 FY | -4.83 Million USD | -46.3% |
| 2014 FY | -3.3 Million USD | -25.7% |
| 2013 FY | -2.62 Million USD | -0.24% |
| 2012 FY | -2.62 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -123.771% |
| CSL Limited | 3.7 Billion USD | 100.085% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 95.63% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 163.833% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -1098.679% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 82.421% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 103.833% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -104.242% |
| Mesoblast Limited | -84.14 Million USD | 96.272% |
| Marizyme, Inc. | -34.08 Million USD | 90.796% |
| Genus plc | 6.4 Million USD | 149.02% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 132.202% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -236.839% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 62.428% |
| ContraFect Corporation | -56.88 Million USD | 94.485% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 31.121% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| IMV Inc. | -38.67 Million USD | 91.887% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -14.047% |
| MultiCell Technologies, Inc. | -722.81 USD | -433935.777% |
| Accustem Sciences Inc. | -3.74 Million USD | 16.26% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 94.682% |
| EV Biologics, Inc. | -483.06 Thousand USD | -549.452% |
| Q BioMed Inc. | -3.44 Million USD | 8.949% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 188.623% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -19.4% |
| Biomind Labs Inc. | -1 Million USD | -210.741% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 52.809% |
| Skye Bioscience, Inc. | -13.67 Million USD | 77.053% |
| SQZ Biotechnologies Company | -75.82 Million USD | 95.863% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -10374.272% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 37.808% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -10.06% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 80.231% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -705.312% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | 35.706% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -57.93% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -62.332% |
| GB Sciences, Inc. | -1.42 Million USD | -120.854% |
| Alpha Cognition Inc. | -9.7 Million USD | 67.676% |
| argenx SE | -425.04 Million USD | 99.262% |
| HST Global, Inc. | -140.9 Thousand USD | -2126.471% |
| Halberd Corporation | -75.05 Thousand USD | -4080.219% |
| Enzolytics Inc. | -2.14 Million USD | -46.0% |
| Resverlogix Corp. | -12.74 Million USD | 75.392% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 0.979% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 94.348% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 94.293% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -200.503% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -8.135% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -7.461% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -68.274% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -98.641% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 7.863% |
| AVAX Technologies, Inc. | 6.69 Million USD | 146.874% |
| ONE Bio Corp. | 13.68 Million USD | 122.931% |
| Zenith Capital Corp. | -8.94 Million USD | 64.919% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.245% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -17908.461% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -27.774% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -1729.201% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -56.49% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -178.89% |
| Agentix Corp. | -1.37 Million USD | -128.704% |
| Adynxx, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -3.04 Million USD | -3.191% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -218.809% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -149.781% |
| BioStem Technologies, Inc. | -7.77 Million USD | 59.67% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -1628.657% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -134.924% |
| LadRx Corporation | -3.82 Million USD | 17.951% |
| Cell Source, Inc. | -4.32 Million USD | 27.468% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -655.093% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -356.693% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -356.693% |
| NovAccess Global Inc. | -2.46 Million USD | -27.181% |
| Affymax, Inc. | -15.04 Million USD | 79.149% |
| Itoco Inc. | -919.14 Thousand USD | -241.325% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 25.98% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -180.362% |
| CytoDyn Inc. | -18.05 Million USD | 82.627% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -12364.259% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -1325.519% |
| Qrons Inc. | -643.67 Thousand USD | -387.396% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -455.539% |
| SYBLEU INC | -149.18 Thousand USD | -2002.999% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -40.692% |
| Rebus Holdings, Inc. | -664 Thousand USD | -372.478% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -72.726% |
| Mobile Lads Corp. | -554.55 Thousand USD | -465.73% |
| International Stem Cell Corporation | -663 Thousand USD | -373.191% |
| Bioxytran, Inc. | -3.82 Million USD | 17.876% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -5859.829% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -15324.061% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 91.349% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -93.897% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -326.353% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -0.844% |
| Neutra Corp. | -229.48 Thousand USD | -1267.079% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 82.113% |
| PureTech Health plc | -146.19 Million USD | 97.854% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 85.402% |
| IXICO plc | -1.43 Million USD | -118.32% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 66.945% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 97.424% |
| CSL Limited | 3.81 Billion USD | 100.082% |
| Cellectis S.A. | -108.85 Million USD | 97.118% |